Later this summer, the Food and Drug Administration is expected to decide whether the chemical found in the drug ecstasy can be used as a treatment for post-traumatic stress disorder. FDA approval of ...
Taking antidepressant medication at the same time as MDMA is associated with a lower rate of fatal outcomes compared to other ...
VANCOUVER, British Columbia, July 31, 2023 (GLOBE NEWSWIRE) -- PharmAla Biotech Holdings Inc. (“PharmAla” or the “Company”) (CSE: MDMA) (OTC:PMBHF), a biotechnology company focused on the research, ...
There's excitement and controversy swirling around the potential use of MDMA for treating post-traumatic stress disorder. On Tuesday, a panel of advisers to the FDA will evaluate the data. MDMA is ...
VANCOUVER, British Columbia, Jan. 08, 2024 (GLOBE NEWSWIRE) -- PharmAla Biotech Holdings Inc. (“PharmAla” or the “Company”) (CSE: MDMA) (OTC:PMBHF), a biotechnology company focused on the research, ...
A decades-long campaign to legalize MDMA as a mainstream medical treatment will reach a climax as soon as Friday, with the Food and Drug Administration poised to decide whether the psychedelic should ...
TORONTO, May 13, 2026 (GLOBE NEWSWIRE) -- PharmAla Biotech Holdings Inc. (CSE: MDMA) (OTCQB: MDXXF) (“PharmAla” or the “Company”), a leader in the research, development, and manufacturing of ...
Inside these vaults lies millions of dollars worth of medicine used in controversial therapies.
MDMA — the chemical found in the drug ecstasy — has appeared effective for treating PTSD in clinical trials. But there are concerns about the quality of the research. Later this summer, the Food and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results